KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Experimental and Clinical Medicine / 2022 / Cilt: 39 - Sayı: 3

COVID-19 infection may trigger SLE disease: a case report

Ebru ATALAR
Yüksel MARAŞ
Nuran SÜNGÜ
Şimal KÖKSAL CEVHER
Meryem KELEŞ
Bünyamin POLAT
Sayfa
901–903
Yayın Tarihi
2022-08-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the present study, a 20-year-old patient with COVID infection, who was diagnosed with SLE with renal involvement according to EULAR/ACR 2019 criteria by considering histopathological and immunofluorescence findings, is presented and discussed with the information in the literature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs of the body especially the skin, joints, hematopoietic system, kidneys and central nervous system.
📊
Temel Bulgular & Veri:The signs and symptoms occur depending on the inflammation in the affected tissues.
💡
Sonuç & Katkı:In the present study, a 20-year-old patient with COVID infection, who was diagnosed with SLE with renal involvement according to EULAR/ACR 2019 criteria by considering histopathological and immunofluorescence findings, is presented and discussed with the information in the literature.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Lupus Erythematosus · systemic · COVID-19

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs of the body especially the skin, joints, hematopoietic system, kidneys and central nervous system. The signs and symptoms occur depending on the inflammation in the affected tissues. Although many factors are responsible in its aetiology, it is known that some viruses such as Epstein Bar may also cause this disease by triggering autoimmunity. Recent studies have revealed that immune system could be activated due to coronavirus infections and that some autoantibodies could be seen in blood. A small number of SLE cases activated by COVID infection have been reported in the literature. In the present study, a 20-year-old patient with COVID infection, who was diagnosed with SLE with renal involvement according to EULAR/ACR 2019 criteria by considering histopathological and immunofluorescence findings, is presented and discussed with the information in the literature.

🔖

Bu Makaleye Atıf Yap

ATALAR, E., MARAŞ, Y., SÜNGÜ, N., CEVHER, Ş. K., KELEŞ, M., POLAT, B. (2022). COVID-19 infection may trigger SLE disease: a case report. Journal of Experimental and Clinical Medicine, Cilt: 39 - Sayı: 3, 901–903. https://ajindex.com/articles/677671

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, et al. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol 2005; 141(3): 500–508
  2. Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol 2020;11:827
  3. Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19. Clin Transl Sci 2020;13:1077–1086
  4. Rubino S, Kelvin N, Bermejo-Martin JF, Kelvin D. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. J Infect Dev Ctries 2020;31;14(3):265-267
  5. Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol 2020;2: 393–400
  6. Bonometti R, Sacchi MC, Stobbione P, Lauritano EC, Tamiazzo S, Marchegiani A, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci 2020;24: 9695–9697
  7. Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 2020;39(9):2811–2815
  8. Gracia-Ramos AE, Saavedra-Salinas MÁ. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol Int 2021;41: 799–809
  9. Zamani B, Moeini Taba S-M, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep 2021;15: 29
  10. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019;78: 1151–1159
  11. Barbhaiya M, Costenbader KH. Environmental exposures and the development of systemic lupus erythematosus. Curr Opin Rheumatol 2016;28: 497–505
  12. Losa F, Firinu D, Deidda M, Costanzo G, Del Giacco SR. Clinical pitfalls of leishmaniasis and Whipple's disease hidden behind systemic lupus erythematosus: A case series. Acta Microbiol Immunol Hung 2019;66: 377-385
  13. Li Z-X, Zeng S, Wu H-X, Zhou Y. The risk of systemic lupus erythematosus asso